» Articles » PMID: 33905039

Acute Gastrointestinal Injury and Feeding Intolerance As Prognostic Factors in Critically Ill COVID-19 Patients

Abstract

Background: Although acute gastrointestinal injury (AGI) and feeding intolerance (FI) are known independent determinants of worse outcomes and high mortality in intensive care unit (ICU) patients, the incidence of AGI and FI in critically ill COVID-19 patients and their prognostic importance have not been thoroughly studied.

Methods: We reviewed 218 intubated patients at Stony Brook University Hospital and stratified them into three groups based on AGI severity, according to data collected in the first 10 days of ICU course. We used chi-square test to compare categorical variables such as age and sex and two-sample t-test or Mann-Whitney U-tests for continuous variables, including important laboratory values. Cox proportional hazards regression models were utilized to determine whether AGI score was an independent predictor of survival, and multivariable analysis was performed to compare risk factors that were deemed significant in the univariable analysis. We performed Kaplan-Meier survival analysis based on the AGI score and the presence of FI.

Results: The overall incidence of AGI was 95% (45% AGI I/II, 50% AGI III/IV), and FI incidence was 63%. Patients with AGI III/IV were more likely to have prolonged mechanical ventilation (22 days vs 16 days, P-value <0.002) and higher mortality rate (58% vs 28%, P-value <0.001) compared to patients with AGI 0/I/II. This was confirmed with multivariable analysis which showed that AGI score III/IV was an independent predictor of higher mortality (AGI III/IV vs AGI 0/I/II hazard ratio (HR), 2.68; 95% confidence interval (CI), 1.69-4.25; P-value <0.0001). Kaplan-Meier survival analysis showed that both AGI III/IV and FI (P-value <0.001) were associated with worse outcomes. Patients with AGI III/IV had higher daily and mean D-dimer and CRP levels compared to AGI 0/I/II (P-value <0.0001).

Conclusions: The prevalence of AGI and FI among critically ill COVID-19 patients was high. AGI grades III/IV were associated with higher risk for prolonged mechanical ventilation and mortality compared to AGI 0/I/II, while it also correlated with higher D-dimer and C-reactive protein (CRP) levels. FI was independently associated with higher mortality. The development of high-grade AGI and FI during the first days of ICU stay can serve as prognostic tools to predict outcomes in critically ill COVID-19 patients.

Citing Articles

Ventilatory pressure parameters impact the association between acute gastrointestinal injury and all-cause mortality in mechanically ventilated patients.

Ziqiang S, Jiale L, Renhua S, Aiping W, Yin N, Jingquan L Sci Rep. 2024; 14(1):20763.

PMID: 39237608 PMC: 11377789. DOI: 10.1038/s41598-024-71556-3.


Clinical practice guidelines for nutritional assessment and monitoring of adult ICU patients in China.

Guan X, Chen D, Xu Y J Intensive Med. 2024; 4(2):137-159.

PMID: 38681796 PMC: 11043647. DOI: 10.1016/j.jointm.2023.12.002.


Citrulline, Intestinal Fatty Acid-Binding Protein and the Acute Gastrointestinal Injury Score as Predictors of Gastrointestinal Failure in Patients with Sepsis and Septic Shock.

Tyszko M, Lemanska-Perek A, Smiechowicz J, Tomaszewska P, Biecek P, Gozdzik W Nutrients. 2023; 15(9).

PMID: 37432225 PMC: 10180779. DOI: 10.3390/nu15092100.


Different definitions of feeding intolerance and their associations with outcomes of critically ill adults receiving enteral nutrition: a systematic review and meta-analysis.

Li J, Wang L, Zhang H, Zou T, Kang Y, He W J Intensive Care. 2023; 11(1):29.

PMID: 37408020 PMC: 10320932. DOI: 10.1186/s40560-023-00674-3.


An observational study on factors associated with ICU mortality in Covid-19 patients and critical review of the literature.

Lavrentieva A, Kaimakamis E, Voutsas V, Bitzani M Sci Rep. 2023; 13(1):7804.

PMID: 37179397 PMC: 10182846. DOI: 10.1038/s41598-023-34613-x.


References
1.
Hsu A, Liu Y, Zayac A, Olszewski A, Reagan J . Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia. Thromb Res. 2020; 196:375-378. PMC: 7511207. DOI: 10.1016/j.thromres.2020.09.030. View

2.
Sahu B, Kampa R, Padhi A, Panda A . C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection. Clin Chim Acta. 2020; 509:91-94. PMC: 7274122. DOI: 10.1016/j.cca.2020.06.013. View

3.
Giacobbe D, Battaglini D, Ball L, Brunetti I, Bruzzone B, Codda G . Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest. 2020; 50(10):e13319. PMC: 7323143. DOI: 10.1111/eci.13319. View

4.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

5.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View